When virologist Hilary Koprowski, M.D., reported last month in the Proceedings of the National Academy of Sciences how he and colleagues used tobacco plants to produce cancer-fighting monoclonal antibodies that recognize and hunt down breast and colorectal cancer cells, the work represented another step toward a goal he has been pursuing for the last decade.
